Histamine 2 receptor: Emerging target for the treatment of attention-deficit/hyperactivity disorder.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 40107248.
- Also identified by DOI 10.1016/j.xcrm.2025.102023 and PMC identifier 11970375.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A study by An et al. sheds a novel light on the potential role of histamine 2 receptor (H<sub>2</sub>R) deficiency in attention-deficit/hyperactivity disorder (ADHD), which could be a future therapeutic target of ADHD. This spotlight provides an overview of the current knowledge of the histaminergic system and proposes future directions.
Medical subject headings
- Attention Deficit Disorder with Hyperactivity
- Receptors, Histamine H2